首页 › 肝癌（肝细胞癌） › 加利福尼亚州 › Los Angeles
Los Angeles CA 肝癌（肝细胞癌）临床试验
19项针对 肝癌（肝细胞癌）的研究正在 Los Angeles及周边约 30 英里内的站点招募参与者。打开研究详情可查看入选标准及联系研究团队的方式。
官方研究文本（英文）
正在为研究招募参与者？将此页面置顶展示 — $99 / 30天 →
Symbiotic-GI-13: A Study to Learn About Study Medicine Called PF-08634404 as a Single Treatment and Combination Treatment in Adult Participants With a Liver Cancer Called Hepatocellular Carcinoma, That is Too Advanced to be Removed by Surgery and May Have Spread to Other Parts of the Body.
招募中1/2 期
- START Los Angeles, LLC, Los Angeles
- Keck Hospital of USC, Los Angeles
- Los Angeles General Medical Center, Los Angeles
- 以及另外 3 项
National Liver Cancer Screening Trial
招募中4 期
- University of Southern California, Los Angeles
A Study to Evaluate the Safety and Tolerability of Pumitamig Alone or In Combination With Ipilimumab in Participants With First-Line Advanced or Unresectable Hepatocellular Carcinoma (HCC) (ROSETTA HCC-206)
招募中1/2 期
- Local Institution - 0070, Los Angeles
Safety and Preliminary Anti-Tumor Activity of TYRA-430 in Advanced Hepatocellular Carcinoma and Other Solid Tumors With Activating FGF/FGFR Pathway Aberrations
招募中1 期
- USC Norris Comprehensive Cancer Center, Los Angeles
Visugromab, Nivolumab and Lenvatinib Compared to Double Placebo and Lenvatinib in Unresectable or Metastatic Hepatocellular Carcinoma Post Anti-PD-(L)1 Failure
招募中2 期
- USC Norris Comprehensive Cancer Center, Los Angeles
Real-world Evaluation of the HistoSonics Edison System for Treatment of Liver Tumors Across Multidisciplinary Users (BOOMBOX: Master Study)
招募中观察性研究
- Cedars-Sinai Medical Center, Los Angeles
Phase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment of Hepatocellular Carcinoma
招募中3 期
- Research Site, Los Angeles
Safety, PK and Efficacy of QXL138AM in Patients With Solid Tumors and Multiple Myeloma
招募中1 期
- University of Southern California, Los Angeles
- Cedars-Sanai Medical Center - Samuel Oschin Comprehensive Cancer, Los Angeles
- Cedars-Sanai Medical Center, Los Angeles
Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors
招募中1/2 期
- Children's Hospital Los Angeles, Los Angeles
FOG-001 in Locally Advanced or Metastatic Solid Tumors
招募中1/2 期
- University of California, Los Angeles (UCLA), Los Angeles
First in Human Study to Evaluate AZD9793 in Participants With Advanced or Metastatic Solid Tumours
招募中1/2 期
- Research Site, Los Angeles
A Study of MGC026 in Participants With Advanced Solid Tumors
招募中1 期
- The Angeles Clinic and Research Institute, Los Angeles
A Study to Evaluate the Efficacy and Safety of Ifinatamab Deruxtecan (I-DXd) in Subjects With Recurrent or Metastatic Solid Tumors (IDeate-PanTumor02)
招募中1/2 期
- Los Angeles Cancer Network, Los Angeles
ET140203 T Cells in Pediatric Subjects With Hepatoblastoma, HCN-NOS, or Hepatocellular Carcinoma
招募中1/2 期
- Children's Hospital Los Angeles, Los Angeles
A Study to Evaluate ALN-BCAT in Patients With Hepatocellular Carcinoma
招募中1 期
- Clinical Trial Site, Los Angeles
DB-1311 in Combination With BNT327 or DB-1305 in Advanced/Metastatic Solid Tumors
招募中2 期
- USA06-0, Los Angeles
- USA16-0, Los Angeles
A Study of TTI-101 as Monotherapy and in Combination in Participants With Locally Advanced or Metastatic, and Unresectable Hepatocellular Carcinoma
招募中1/2 期
- Norris Comprehensive Cancer Center, Los Angeles
Multilevel Determinants of Socioeconomic Disparities in Geographic Late-Stage Hepatocellular Carcinoma Hotspots
招募中观察性研究
- USC / Norris Comprehensive Cancer Center, Los Angeles
A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors
招募中1/2 期
- Research Site 125, Los Angeles
- Research Site 133, Los Angeles
- Research Site 103, Los Angeles
其他城市的 肝癌（肝细胞癌）试验
- Houston, TX31 项研究
- New York City, NY24 项研究
- Dallas, TX19 项研究
- Boston, MA18 项研究
- Cleveland, OH18 项研究
- Chicago, IL16 项研究
- Philadelphia, PA16 项研究
- Pittsburgh, PA15 项研究
- San Francisco, CA14 项研究
- Orange, CA14 项研究
- Jacksonville, FL14 项研究
- San Antonio, TX13 项研究
Los Angeles的其他研究
- 非小细胞肺癌87 项研究
- 癌症（所有类型）74 项研究
- 乳腺癌73 项研究
- 前列腺癌61 项研究
- 结直肠癌59 项研究
- 转移性癌症57 项研究
- 卵巢癌50 项研究
- 肺癌45 项研究
- 头颈鳞状细胞癌42 项研究
- 胰腺癌35 项研究
- 子宫内膜癌34 项研究
- 黑色素瘤34 项研究
数据来自 ClinicalTrials.gov，检索日期：2026年10月6日。每项研究自行设定入选标准，由研究团队决定谁能参与。